Results 31 to 40 of about 430,871 (256)

School nurses' experiences of delivering the UK HPV vaccination programme in its first year [PDF]

, 2011
Background: In the United Kingdom (UK) in September 2008, school nurses began delivering the HPV immunisation programme for girls aged 12 and 13 years old. This study offers insights from school nurses' perspectives and experiences of delivering this new
Hilton, S., Hunt, Kate, Petticrew, Mark, Bedford, H., Mark Petticrew, Hunt, K., Bedford, Helen, Hilton, Shona, Shona Hilton, Kate Hunt, Helen Bedford, Petticrew, M., Bedford Helen, Petticrew Mark, Hunt Kate, Hilton Shona   +15 more
core   +2 more sources

Knowledge about cervical cancer risk factors and human papilloma virus vaccine among Saudi women of childbearing age: A community-based cross-sectional study from Saudi Arabia

Vaccine: X, 2023
Objective: To examine the knowledge of cervical cancer risk factors and human papilloma virus (HPV) vaccine among Saudi women of childbearing age. Methods: An anonymous, survey-based, cross-sectional study was conducted from November 2022 to March 2023 ...
Abdulrahim Gari, Manar A. Ghazzawi, Shahad A. Ghazzawi, Shahd M. Alharthi, Elaf A. Yanksar, Rawan M. Almontashri, Raghad Batarfi, Lina I. Kinkar, Saeed Baradwan   +8 more
doaj   +1 more source

Prophylactic HPV vaccines [PDF]

Journal of Clinical Pathology, 2007
The HPV L1 VLP vaccines are immensely important developments in public health and the benefits that they promise are immense, offering the opportunity to prevent, in the long term, 80% of cervical cancers, 60% of vulval cancers and 80% of anal cancers in women. In the short to medium term they will prevent at least 90% of genital warts and have a major
openaire   +3 more sources

"It's a can of worms": understanding primary care practitioners' behaviours in relation to HPV using the Theoretical Domains Framework [PDF]

, 2012
Background: The relationship between infection with high-risk human papillomavirus (HPV) and cervical cancer is transforming cervical cancer prevention. HPV tests and vaccinations have recently become available.
Judith Murphy, Francis, Jill, Stephan U Dombrowski, O’Leary John J, ATHENS Group, Sharpe, L. T., Martin, Cara M, Francis, Jill J, Jill J Francis, McSherry Lisa A, Martin, C. M., Dombrowski, S. U., McSherry, Lisa A, Linda Sharp, John J O’Leary, Cara M Martin, Francis, J., Dombrowski Stephan U, McSherry, L. A., Lisa A McSherry, Martin Cara M, Sharp, Linda, Francis Jill J, null null, Dombrowski, Stephan U, Murphy Judith, O'Leary, J. J., Murphy, J., Sharp Linda, Murphy, Judith, O'Leary, John J   +30 more
core   +2 more sources

Therapeutic HPV vaccines [PDF]

Best Practice & Research Clinical Obstetrics & Gynaecology, 2018
High-risk human papillomavirus (HPV) infection is known to be a necessary factor for cervical and anogenital malignancies. Cervical cancers account for over a quarter of a million deaths annually. Despite the availability of prophylactic vaccines, HPV infections remain extremely common worldwide.
Hancock, G, Hellner, K, Dorrell, L
openaire   +3 more sources

Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines [PDF]

, 2010
This study evaluated human papillomavirus (HPV) type prevalence in 370 Scottish invasive cervical cancers (ICCs) using HPV genotyping and HPV mRNA ...
Millan, D, Cubie, Heather, Cuschieri, Kate, D H Brewster, Brewster, D H, C Graham, K Cuschieri, S Nicoll, H A Cubie, Murray, G, Graham, C, A R W Williams, Nicoll, S, D Millan, Hardie, A, J Imrie, Imrie, J, A Hardie, Williams, A R W, G Murray   +19 more
core   +1 more source

Detection and genotyping of human Papillomavirus in urine samples from unvaccinated male and female adolescents in Italy [PDF]

, 2013
The introduction of vaccination against Human Papillomavirus (HPV) in adolescent girls in 2006 has focused virological surveillance on this age group. As few studies have evaluated HPV infections in young populations, further data are needed in order to ...
Zotti, CM, Boccalini, Sara, Elisabetta Tanzi, Gasparini Roberto, Coppola Rosa Cristina, R. Gasparini, Rosa Cristina Coppola, Coppola, RC, Gasparini R, Paolo Castiglia, M. Martinelli, M. Martinese, Panatto D, Silvia Bianchi, Amicizia, D, Amicizia D, Paolo Bonanni, Zotti CM, Elena Rosanna Frati, Bianchi S, Bianchi, S, Martinelli, M, Castiglia Paolo, Bianchi Silvia, D. Panatto, Marianna Martinelli, Meloni, Angelo, Tanzi Elisabetta, Amicizia, Daniela, G. Masia, Masia Giuseppina, Zotti, Carla Maria, Bianchi, Silvia, Daniela Amicizia, Bonanni, Paolo, Martinese M, Martinese, M, Masia G, Castiglia, Paolo Giuseppino, Tanzi, Elisabetta, S. Bianchi, Morena Martinese, C. M. Zotti, P. Castiglia, Coppola R C, Boccalini, S, Amicizia Daniela, Boccalini S, Martinelli Marianna, Bonanni Paolo, Bonanni P, Panatto, Donatella, Panatto Donatella, Frati, ER, Tanzi E, Zotti Carla Maria, Martinelli, Marianna, Frati ER, Piana Andrea, Tanzi, E., Piana A, Martinese, Morena, Gasparini, Roberto, Gasparini, R, Castiglia P, Donatella Panatto, Meloni Angelo, Martinese Morena, Sara Boccalini, D. Amicizia, E. Tanzi, Andrea Piana, P. Bonanni, Panatto, D, Meloni, A, Frati, Elena Rosanna, Masia, Giuseppina, Piana, Andrea Fausto, Boccalini Sara, Giuseppina Masia, R. C. Coppola, A. Meloni, E.R. Frati, Angelo Meloni, S. Boccalini, Roberto Gasparini, Frati Elena Rosanna, Masia, G, A. Piana, Martinelli M, Coppola, Rosa Cristina, Meloni A, Carla Maria Zotti, Bonanni, P   +93 more
core   +2 more sources

HPV Vaccine Hesitancy Among Medical Students in China: A Multicenter Survey

Frontiers in Public Health, 2022
Human papillomavirus (HPV) is the most common genital tract virus infection and can cause genital warts and cervical cancer. This multicenter study examined HPV information sources, vaccine hesitancy, and the association between the two variables.
Liangru Zhou, Jian Wang, Pengxin Cheng, Yue Li, Guoxiang Liu, Xin Zhang   +5 more
doaj   +1 more source

HPV vaccine development after more than ten years approval

Majalah Obstetri dan Ginekologi, 2020
At present, ten years have passed since the human papillomavirus (HPV) vaccine was first approved for use in humans. Research related to HPV vaccine, both in terms of effectiveness and immugenicity in its development, has been widely carried out, such as
Brahmana Askandar
doaj   +1 more source

Understanding confidence in the human papillomavirus vaccine in Japan: a web-based survey of mothers, female adolescents, and healthcare professionals

Human Vaccines & Immunotherapeutics, 2021
Vaccine confidence reflects social, individual, and political factors indicating confidence in vaccines and associated health systems. In Japan, the government ceased proactive recommendation of the human papillomavirus (HPV) vaccine in June 2013, only ...
Michiko Shuto, Youngju Kim, Kotoba Okuyama, Kazunobu Ouchi, Hideo Ueichi, Chimeremma Nnadi, Heidi J. Larson, Gonzalo Perez, Shin Sasaki   +8 more
doaj   +1 more source